GATA6 and neoplasm: Our observations suggest a tumour-suppressive role of GATA6 in human PDAC, concordant with our findings for mouse PDAC.18 This notion is at odds with the occurrence of GATA6 amplifications in 10%–20% of PDACs,15, 16, 32 which led to the proposal that it is a PDAC oncogene.